• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • CMDE Preps for AI Software to Soar in China

CMDE Preps for AI Software to Soar in China

Tuesday, 24 November 2020 / Published in Medical Device, News, NMPA Registration in China

CMDE Preps for AI Software to Soar in China

On October 30, the CMDE (Center for Medical Device Evaluation) of NMPA (National Medical Products Administration) announced their plan to draft the clinical evaluation and performance evaluation guidelines for AI software in diagnostic pathology. Both clinical evaluation and performance evaluation are part of the reviewing process of the product registrations in China.

According to the China’s Five-Year Plans and Made in China 2025, the development goals covered imaging equipment, AI robotics, wearables, remote diagnosis and treatment, etc. Based on reports from the NMPA, the medical imaging equipment currently takes up to 16% of the entire China medical device market. Also, 80% of the registered medical imaging equipment in China are supplied by foreign manufacturers. In January 2020, the DEEPVESSEL FFR was the first AI medical imaging equipment to be registered in China via the fast-track approval procedure.

Under the influence of China’s strategic policies, the AI medical imaging industry is expected to have a subsequent growth in China, and the outlook remains positive for importing AI software products with its current significant market share.

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: AI medical devices, five-year plan, medical imaging equipment, SaMD, Software as Medical Device

What you can read next

AI Regulatory Developments and Planning Issued by China Regulator
Registration of Cosmetics Might Soon be Possible Without Animal Tests
How to Register Children Cosmetics In China Clarified

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.